Clinical Analysis of Microvascular Reconstruction Combined With Decompressive Craniectomy in Patients With Malignant

Yumin Yang1, Xiaodong Long1, Aiguo Li1

  • 1Department of Neurosurgery, People's Hospital of Deyang City, Deyang, China.

World Neurosurgery
|April 15, 2023
PubMed
Abstract

Insights

Microvascular reconstruction with decompressive craniectomy improved outcomes for malignant middle cerebral artery infarctions (MMCA). Patients showed better neurological recovery at 3 months, suggesting this approach is a viable treatment option.

Area of Science:

  • Neurosurgery
  • Vascular Surgery
  • Neurology

Background:

  • Malignant middle cerebral artery infarctions (MMCA) carry a high mortality rate.
  • Decompressive craniectomy (DHC) is a standard treatment, but outcomes can be improved.

Purpose of the Study:

  • To evaluate the safety and efficacy of microvascular reconstruction combined with DHC for MMCA.
  • To compare outcomes between patients receiving revascularization and those undergoing DHC alone.

Main Methods:

  • Retrospective study of MMCA patients aged <60 years.
  • Patients underwent DHC with or without emergency vascular revascularization within 5 days of stroke onset.
  • Outcomes assessed using the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRs).

Main Results:

  • The treatment group (DHC + revascularization) showed a trend towards lower NIHSS scores at 7 days post-operation.
  • At 3 months post-surgery, the treatment group had significantly lower mRs scores (P=0.002).
  • Significant improvement in mRs scores from baseline was observed in the treatment group at 3 months (P<0.05).

Conclusions:

  • Open surgical revascularization combined with DHC improves early cerebral perfusion and neurological recovery in MMCA patients.
  • This combined approach offers a potential treatment option for MMCA when surgeons are trained and hospitals are equipped.

Related Concept Videos